These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2802111)

  • 21. Specific IgE response toward allergenic molecules during perennial hyposensitization: a three-year prospective double-blind study.
    Osterballe O; Ipsen H; Weeke B; Løwenstein H
    J Allergy Clin Immunol; 1983 Jan; 71(1 Pt 1):40-6. PubMed ID: 6337196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and immunological response to oral and subcutaneous immunotherapy with grass pollen extracts. A prospective study.
    Rebien W; Puttonen E; Maasch HJ; Stix E; Wahn U
    Eur J Pediatr; 1982 Jul; 138(4):341-4. PubMed ID: 7128644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy--implications for immunotherapy?
    Darsow U; Brockow K; Pfab F; Jakob T; Petersson CJ; Borres MP; Ring J; Behrendt H; Huss-Marp J
    Clin Exp Allergy; 2014; 44(5):778-86. PubMed ID: 24598010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyposensitization therapy with whole pollen extract or purified allergens monitored by immunoblotting.
    Jarolim E; Matthiesen F; Skov PS; Tejkl M; Oesterballe O; Poulsen LK
    Int Arch Allergy Appl Immunol; 1990; 92(3):254-64. PubMed ID: 1703516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunotherapy to deciduous tree pollens: specific IgE and IgG antibody patterns.
    Möller C; Dreborg S; Einarsson R
    Clin Allergy; 1987 Nov; 17(6):551-62. PubMed ID: 3436034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE.
    Cox LS; Casale TB; Nayak AS; Bernstein DI; Creticos PS; Ambroisine L; Melac M; Zeldin RK
    J Allergy Clin Immunol; 2012 Dec; 130(6):1327-34.e1. PubMed ID: 23122534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Both sublingual and supralingual routes of administration are effective in long-term allergen-specific immunotherapy.
    Panzner P; Petráš M; Sýkora T; Lesná IK; Liška M
    Allergy Asthma Proc; 2011; 32(2):142-50. PubMed ID: 21439167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [IgE and IgG antibody response in patients with type I allergy to birch pollen].
    Rumpold H; Jarolim E; Bonitz W; Tejkl M; Breitenbach M; Scheiner O; Kraft D
    Wien Klin Wochenschr; 1989 Feb; 101(3):107-10. PubMed ID: 2922932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral administration of grass pollen to hay fever patients. An efficacy study in oral hyposensitization.
    Taudorf E; Laursen LC; Djurup R; Kappelgaard E; Pedersen CT; Søborg M; Wilkinson P; Weeke B
    Allergy; 1985 Jul; 40(5):321-35. PubMed ID: 3898904
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever.
    Platts-Mills TA
    J Immunol; 1979 Jun; 122(6):2218-25. PubMed ID: 448124
    [No Abstract]   [Full Text] [Related]  

  • 33. Rush immunotherapy with a standardized Bermuda grass pollen extract.
    Armentia-Medina A; Blanco-Quiros A; Martin-Santos JM; Alvarez-Cuesta E; Moneo-Goiri I; Carreira P; Losada-Cosmes E
    Ann Allergy; 1989 Aug; 63(2):127-35. PubMed ID: 2669567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergen-antibody complex immunotherapy.
    Machiels JJ; Somville MA; Jacquemin MG; Saint-Remy JM
    Allergy; 1991 Jul; 46(5):335-48. PubMed ID: 1928657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of IgM, IgE and IgG(1-4 )antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms.
    Niederberger V; Niggemann B; Kraft D; Spitzauer S; Valenta R
    Eur J Immunol; 2002 Feb; 32(2):576-84. PubMed ID: 11828375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoglobulins in nasal secretion with special reference to IgE. II. Seasonal studies of Timothy-specific IgE-antibody in patients with allergic rhinitis.
    Deuschl H
    Int Arch Allergy Appl Immunol; 1976; 52(1-4):376-83. PubMed ID: 1017895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complexes of grass pollen allergens and specific antibodies reduce allergic symptoms and inhibit the seasonal increase of IgE antibody.
    Machiels JJ; Buche M; Somville MA; Jacquemin MG; Saint-Remy JM
    Clin Exp Allergy; 1990 Nov; 20(6):653-60. PubMed ID: 2083405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunotherapy with partially purified and standardized tree pollen extracts. III. Specific IgE response to the major allergens of alder, birch and hazel pollen during immunotherapy.
    Ipsen H; Schwartz B; Wihl JA; Petersen BN; Munch EP; Janniche H; Løwenstein H
    Allergy; 1988 Jul; 43(5):370-7. PubMed ID: 3046407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyposensitization of patients with allergic rhinitis by intranasal administration of chemically modified grass pollen allergen. A pilot study.
    Deuschl H; Johansson GO
    Acta Allergol; 1977 Aug; 32(4):248-62. PubMed ID: 578362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.